Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis

por Constantinescu, Cris S., Asher, Aliya, Fryze, Waldemar, Kozubski, Wojciech, Wagner, Frank, Aram, Jehan, Tanasescu, Radu, Korolkiewicz, Roman P., Dirnberger-Hertweck, Maren, Steidl, Stefan, Libretto, Susan E., Sprenger, Till, Radue, Ernst W.
Publicado 2015

Dabigatran initiation in patients with non-valvular AF and first acute ischaemic stroke: a retrospective observational study from the SITS registry

por Escudero-Martinez, Irene, Mazya, Michael, Teutsch, Christine, Lesko, Norbert, Gdovinova, Zuzana, Barbarini, Leonardo, Fryze, Waldemar, Karlinski, Michal, Kobayashi, Adam, Krastev, Georgi, Paiva Nunes, Ana, Pasztoova, Katarina, Peeters, André, Sobolewski, Piotr, Vilionskis, Aleksandras, Toni, Danilo, Ahmed, Niaz
Publicado 2020

Modified Rio Score with Platform Therapy Predicts Treatment Success with Fingolimod and Natalizumab in Relapsing-Remitting Multiple Sclerosis Patients

por Jamroz-Wiśniewska, Anna, Zajdel, Radosław, Słowik, Agnieszka, Marona, Monika, Wnuk, Marcin, Adamczyk-Sowa, Monika, Adamczyk, Bożena, Lasek-Bal, Anetta, Puz, Przemysław, Stęposz, Arkadiusz, Krzystanek, Ewa, Patalong-Ogiewa, Maja, Pokryszko-Dragan, Anna, Budrewicz, Sławomir, Koziarska, Dorota, Karbicka, Anna, Wawrzyniak, Sławomir, Fryze, Waldemar, Furtak-Niczyporuk, Marzena, Rejdak, Konrad
Publicado 2021